{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:51:29Z","timestamp":1715986289696},"reference-count":90,"publisher":"Informa Healthcare","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1517\/13543784.12.8.1281","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T21:15:30Z","timestamp":1115241330000},"page":"1281-1295","source":"Crossref","is-referenced-by-count":24,"title":["Agents in clinical development for the treatment of chronic hepatitis B"],"prefix":"10.1517","volume":"12","author":[{"given":"Anneke K","family":"Raney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K","family":"Hamatake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,3,2]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712113372406"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.11.2.169"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1128\/JVI.67.12.7414-7422.1993","volume":"67","author":"KLINGMULLER U","year":"1993","journal-title":"1 Virol."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(86)90602-1"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6599"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1128\/JVI.71.4.2996-3004.1997","volume":"71","author":"LANFORD RE","year":"1997","journal-title":"Viral."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880515)61:10<1957::AID-CNCR2820611004>3.0.CO;2-0"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1159\/000024970"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/JVI.65.3.1310-1317.1991","volume":"65","author":"SUMMERS J","year":"1991","journal-title":"J. Vire]."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JVI.64.6.2819-2824.1990","volume":"64","author":"SUMMERS J","year":"1990","journal-title":"' Virel"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.4.1005"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280432"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/AAC.43.8.2017","volume":"43","author":"DELANEY WE","year":"1999","journal-title":"Antlinicrob. Agents Chernother."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/AAC.42.12.3200","volume":"42","author":"SEIFER M","year":"1998","journal-title":"Antimicrob. Agents Chernother."},{"key":"CIT0018","first-page":"893","volume":"299","author":"DERES K","year":"2003","journal-title":"PAESSENS A et a\/.: Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.6.2235"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.0038"},{"key":"CIT0022","first-page":"1488","volume":"33","author":"MEHTA A","year":"2001","journal-title":"CONYERS Bet al.: Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatelogy"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.000333"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90624-4"},{"key":"CIT0026","first-page":"1051","volume":"90","author":"ODA T","year":"1999","journal-title":"fpn..1. Cancer Res."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.71.3.2192-2201.1997","volume":"71","author":"MILICH DR","year":"1997","journal-title":"Viral."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1040516"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80078-1"},{"issue":"15","key":"CIT0031","first-page":"1899\u2013","volume":"2001","author":"CHAN HL","year":"1905","journal-title":"flier"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270527"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(97)89891-3"},{"key":"CIT0034","first-page":"917","volume":"34","author":"POL S","year":"2001","journal-title":"DRISS Fetal.: Efficacy and limitations of a specific immunotherapy in chronic hepatitis B. Hepatol"},{"key":"CIT0035","first-page":"531","volume":"30","author":"HEATHCOTE J","year":"1999","journal-title":"The CY1899 T Cell Vaccine Study Group. Hepatology"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21594"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-8-629"},{"key":"CIT0038","first-page":"295","volume":"323","author":"PERRILLO RP","year":"1990","journal-title":"The Hepatitis Interventional Therapy Group. N Engl. I Med."},{"key":"CIT0039","first-page":"312","volume":"119","author":"WONG DK","year":"1993","journal-title":"Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann. Intern. Med."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701303360507"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.8.1289"},{"key":"CIT0043","first-page":"61","volume":"339","author":"LAI CL","year":"1998","journal-title":"Asia Hepatitis Lamivudine Study Group. N Engl. I Med."},{"key":"CIT0045","first-page":"889","volume":"29","author":"TASSOPOULOS NC","year":"1999","journal-title":"Lamivudine Precore Mutant Study Group. Hepatology"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910213411702"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v113.pm9322520"},{"key":"CIT0050","first-page":"301A","volume":"36","author":"LAI CL","year":"2002","journal-title":"Hepatology"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25084"},{"key":"CIT0053","first-page":"172","volume":"119","author":"LIAW YF","year":"2000","journal-title":"Asia Hepatitis Lamivudine Study Group. Gastroenterology"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80476-X"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27834"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300221"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80076-8"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020681"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021812"},{"key":"CIT0062","first-page":"L111","volume":"7","author":"WILLEMS B","year":"2002","journal-title":"Antiviral flier"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360728"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1705-1713.2001"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34740"},{"key":"CIT0066","first-page":"A43","volume":"57","author":"GIBBS CS","year":"2003","journal-title":"Antiviral Res."},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109070-00013"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.21747"},{"key":"CIT0069","unstructured":"COOKSLEY G. 11th International Symposium on Viral Hepatitis and Liver Disease, Sydney, Australia (2003)."},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/AAC.43.1.190","volume":"43","author":"YAMANAKA G","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0071","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/AAC.41.7.1444","volume":"41","author":"INNAIMO SF","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1128\/AAC.42.12.3209","volume":"42","author":"GENOVESI EV","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1086\/324003"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.1.82-88.2002"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11100"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2525-2532.2002"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25959"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.37058"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.4.683"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26815"},{"key":"CIT0082","first-page":"300A","volume":"36","author":"CHANG TT","year":"2002","journal-title":"Hepatology"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.19.8495"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.12.2686"},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1096\/fasebj.13.12.1511","volume":"13","author":"FENG JY","year":"1999","journal-title":"FASEB.I."},{"key":"CIT0087","first-page":"349A","volume":"34","author":"LEUNG N","year":"2001","journal-title":"Hepatology"},{"key":"CIT0089","first-page":"372A","volume":"36","author":"GISH R","year":"2002","journal-title":"Hepatology"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1728-1733.2002"},{"key":"CIT0091","first-page":"229","volume":"45","author":"BRYANT ML","year":"2001","journal-title":"PLACIDI Let al.: Antiviral L-nucleosides specific for hepatitis B virus infection. Antimicrob. Agents Chemother."},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1177\/095632020101200205"},{"key":"CIT0096","first-page":"A26","volume":"17","author":"LIM SG","year":"2002","journal-title":"Castroenterol. Hepatol."},{"key":"CIT0097","first-page":"785","volume":"34","author":"YUEN ME SABLON E,","year":"2001","journal-title":"HUI CK et al.: Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy. Hepatology"},{"key":"CIT0098","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.42.2.369","volume":"42","author":"AGUESSE-GERMON S","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0099","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/AAC.40.2.380","volume":"40","author":"BALAKRISHNA PAI S","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.20899"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00747-3"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(98)00277-7"},{"key":"CIT0108","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.42.7.1805","volume":"42","author":"ZHU YL","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0114","unstructured":"DUNKLE LM: Elvucitabine: A potent nucleoside for treatment of multi-drug resistant hepatitis B and HIV. 16th ICAR Pre-conference satellite symposium 'Clinical Update on Anti viral Drugs: Savannah, GA, USA (2003)."},{"key":"CIT0115","first-page":"301A","volume":"36","author":"ERION MD","year":"2002","journal-title":"Hepatology"},{"key":"CIT0116","unstructured":"HONG Z: Hepavir B: A safer and liver-targeting prodrug of PMEA. 4th International Antiviral Drug Discovery and Development Summit. Princeton, NJ, USA (2003)."},{"key":"CIT0117","unstructured":"HONG Z: Clinical development of hepavir B: A liver targeting prodrug of PMEA. 16th ICAR Pre-conference satellite symposium 'Clinical Update on Anti viral Drugs: Savannah, GA, USA (2003)."},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.9.4398"},{"key":"CIT0120","first-page":"A43","volume":"57","author":"ZOULIM F","year":"2003","journal-title":"Antiviral Res."}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.12.8.1281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T06:41:22Z","timestamp":1586241682000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.12.8.1281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":90,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2005,3,2]]},"published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1517\/13543784.12.8.1281"],"URL":"https:\/\/doi.org\/10.1517\/13543784.12.8.1281","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}